Distinguished in Interstitial Lung Disease

Dr. Mehdi S. Mirsaeidi

Pulmonary Medicine
University Of Florida Jacksonville Physicians, Inc.
15255 Max Leggett Pkwy, Suite 3600, 
Jacksonville, FL 
Accepting New Patients
Offers Telehealth
Distinguished in Interstitial Lung Disease
University Of Florida Jacksonville Physicians, Inc.
15255 Max Leggett Pkwy, Suite 3600, 
Jacksonville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mehdi Mirsaeidi is a Pulmonary Medicine provider in Jacksonville, Florida. Dr. Mirsaeidi is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lymphofollicular Hyperplasia, Mycobacterium Avium Complex Infections, and Lung Transplant. Dr. Mirsaeidi is currently accepting new patients.

His clinical research consists of co-authoring 195 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 27 articles in the study of Interstitial Lung Disease.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in TX
Hospital Affiliations
Shands Jacksonville
Languages Spoken
English
Farsi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
15255 Max Leggett Pkwy, Suite 3600, Jacksonville, FL 32218
Other Locations
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
10475 Centurion Pkwy N, Suite 201, Jacksonville, FL 32256
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
653 W 8th St, Jacksonville, FL 32209
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
655 W 8th St, Jacksonville, FL 32209

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Drug
Study Phase: Phase 2
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2024
Intervention Type: Drug
Study Drugs: Azithromycin, Ethambutol, Rifampin
Study Phase: Phase 2/Phase 3
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Two-Stage, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19
A Two-Stage, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (Dendrimer N-acetyl-cysteine) in Patients With Severe COVID-19
Enrollment Status: Terminated
Publish Date: February 13, 2023
Intervention Type: Drug
Study Drug: OP-101
Study Phase: Phase 2
Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer
Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer
Enrollment Status: Completed
Publish Date: May 04, 2022
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Potential Efficacy of BACTELIDE vs. Placebo in Addition to Standard-of-care Therapy for S. Aureus, P. Aeruginosa, and K. Pneumoniae Colonized Pressure Injuries
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Potential Efficacy of BACTELIDE vs. Placebo in Addition to Standard-of-care Therapy for S. Aureus, P. Aeruginosa, and K. Pneumoniae Colonized Pressure Injuries
Enrollment Status: Unknown
Publish Date: December 21, 2021
Intervention Type: Combination product, Procedure
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

194 Total Publications

Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis.
Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis.
Journal: Metabolites
Published: August 03, 2025
Similar Doctors
Augustine S. Lee
Distinguished in Interstitial Lung Disease
Dr. Augustine S. Lee
Pulmonary Medicine
Distinguished in Interstitial Lung Disease
Dr. Augustine S. Lee
Pulmonary Medicine

Mayo Clinic Jacksonville

4500 San Pablo Rd S, 
Jacksonville, FL 
 (19.1 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Augustine Lee is a Pulmonary Medicine provider in Jacksonville, Florida. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Bronchiectasis, Lung Transplant, and Advanced Bronchoscopy. Dr. Lee is currently accepting new patients.

Distinguished in Interstitial Lung Disease
Dr. Isabel C. Mira-Avendano
Pulmonary Medicine
Distinguished in Interstitial Lung Disease
Dr. Isabel C. Mira-Avendano
Pulmonary Medicine
4500 San Pablo Rd S, 
Jacksonville, FL 
 (19.1 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Isabel Mira-Avendano is a Pulmonary Medicine provider in Jacksonville, Florida. Dr. Mira-Avendano is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pneumonia, and Pulmonary Fibrosis. Dr. Mira-Avendano is currently accepting new patients.

Distinguished in Interstitial Lung Disease
Dr. Hassan Z. Baig
Pulmonary Medicine
Distinguished in Interstitial Lung Disease
Dr. Hassan Z. Baig
Pulmonary Medicine

Mayo Clinic Jacksonville

4500 San Pablo Rd S, 
Jacksonville, FL 
 (19.1 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hassan Baig is a Pulmonary Medicine provider in Jacksonville, Florida. Dr. Baig is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Metastases, Pneumonia, and Orchiectomy. Dr. Baig is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mirsaeidi's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile